108 related articles for article (PubMed ID: 2436253)
1. The abnormal prostate: MR imaging at 1.5 T with histopathologic correlation.
Carrol CL; Sommer FG; McNeal JE; Stamey TA
Radiology; 1987 May; 163(2):521-5. PubMed ID: 2436253
[TBL] [Abstract][Full Text] [Related]
2. Prostatic carcinoma and benign prostatic hyperplasia: MR imaging with histopathologic correlation.
Kahn T; Bürrig K; Schmitz-Dräger B; Lewin JS; Fürst G; Mödder U
Radiology; 1989 Dec; 173(3):847-51. PubMed ID: 2479050
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
Kurhanewicz J; Vigneron DB; Hricak H; Narayan P; Carroll P; Nelson SJ
Radiology; 1996 Mar; 198(3):795-805. PubMed ID: 8628874
[TBL] [Abstract][Full Text] [Related]
4. [Magnetic resonance tomography of prostatic cancer. A histopathologic correlation].
Kahn T; Bürrig KF; Schmitz-Dräger B; Fürst G; Stork W; Mödder U
Radiologe; 1989 Mar; 29(3):144-9. PubMed ID: 2469100
[TBL] [Abstract][Full Text] [Related]
5. Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology.
Jager GJ; Ruijter ET; van de Kaa CA; de la Rosette JJ; Oosterhof GO; Thornbury JR; Barentsz JO
AJR Am J Roentgenol; 1996 Apr; 166(4):845-52. PubMed ID: 8610561
[TBL] [Abstract][Full Text] [Related]
6. MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy.
Silverman JM; Krebs TL
AJR Am J Roentgenol; 1997 Feb; 168(2):379-85. PubMed ID: 9016212
[TBL] [Abstract][Full Text] [Related]
7. Prostatic carcinoma and benign prostatic hyperplasia: inability of MR imaging to distinguish between the two diseases.
Ling D; Lee JK; Heiken JP; Balfe DM; Glazer HS; McClennan BL
Radiology; 1986 Jan; 158(1):103-7. PubMed ID: 2416005
[TBL] [Abstract][Full Text] [Related]
8. High-grade prostatic intraepithelial neoplasia in patients with prostate cancer: MR and MR spectroscopic imaging features--initial experience.
Hom JJ; Coakley FV; Simko JP; Lu Y; Qayyum A; Westphalen AC; Schmitt LD; Carroll PR; Kurhanewicz J
Radiology; 2007 Feb; 242(2):483-9. PubMed ID: 17179396
[TBL] [Abstract][Full Text] [Related]
9. Pathologic characterization of human prostate tissue with proton MR spectroscopy.
Swindle P; McCredie S; Russell P; Himmelreich U; Khadra M; Lean C; Mountford C
Radiology; 2003 Jul; 228(1):144-51. PubMed ID: 12832578
[TBL] [Abstract][Full Text] [Related]
10. Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings.
Schiebler ML; Tomaszewski JE; Bezzi M; Pollack HM; Kressel HY; Cohen EK; Altman HG; Gefter WB; Wein AJ; Axel L
Radiology; 1989 Jul; 172(1):131-7. PubMed ID: 2472644
[TBL] [Abstract][Full Text] [Related]
11. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy.
Kurhanewicz J; Vigneron DB; Nelson SJ; Hricak H; MacDonald JM; Konety B; Narayan P
Urology; 1995 Mar; 45(3):459-66. PubMed ID: 7533458
[TBL] [Abstract][Full Text] [Related]
12. Prostatic disorders: MR imaging at 1.5 T.
Phillips ME; Kressel HY; Spritzer CE; Arger PH; Wein AJ; Marinelli D; Axel L; Gefter WB; Pollack HM
Radiology; 1987 Aug; 164(2):386-92. PubMed ID: 2440074
[TBL] [Abstract][Full Text] [Related]
13. Hormonal ablation of prostatic cancer: effects on prostate morphology, tumor detection, and staging by endorectal coil MR imaging.
Chen M; Hricak H; Kalbhen CL; Kurhanewicz J; Vigneron DB; Weiss JM; Carroll PR
AJR Am J Roentgenol; 1996 May; 166(5):1157-63. PubMed ID: 8615261
[TBL] [Abstract][Full Text] [Related]
14. Determining the volume of prostatic carcinoma: value of MR imaging with an external-array coil.
Sommer FG; Nghiem HV; Herfkens R; McNeal J; Low RN
AJR Am J Roentgenol; 1993 Jul; 161(1):81-6. PubMed ID: 8517328
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy.
Claus FG; Hricak H; Hattery RR
Radiographics; 2004 Oct; 24 Suppl 1():S167-80. PubMed ID: 15486239
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer: endorectal MR imaging and MR spectroscopic imaging--distinction of true-positive results from chance-detected lesions.
Hom JJ; Coakley FV; Simko JP; Qayyum A; Lu Y; Schmitt L; Carroll PR; Kurhanewicz J
Radiology; 2006 Jan; 238(1):192-9. PubMed ID: 16373767
[TBL] [Abstract][Full Text] [Related]
17. [Clinical use of endorectal coil MR in the study of prostatic pathology with special reference to hyperplasia and carcinoma].
Gualdi GF; Polettini E; Casciani E
Clin Ter; 1996; 147(1-2):51-66. PubMed ID: 8767956
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging.
Kurhanewicz J; Vigneron DB; Hricak H; Parivar F; Nelson SJ; Shinohara K; Carroll PR
Radiology; 1996 Aug; 200(2):489-96. PubMed ID: 8685346
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of prostate cancer in patients with persistently elevated PSA and tumor-negative biopsy in ambulatory care: performance of MR imaging in a multi-reader environment.
Scheidler J; Weöres I; Brinkschmidt C; Zeitler H; Panzer S; Scharf M; Heuck A; Siebels M
Rofo; 2012 Feb; 184(2):130-5. PubMed ID: 22274854
[TBL] [Abstract][Full Text] [Related]
20. Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment?
Brausi M; Castagnetti G; Dotti A; De Luca G; Olmi R; Cesinaro AM
J Urol; 2004 Sep; 172(3):906-8; discussion 908-9. PubMed ID: 15310995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
